5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | BUY | NEUTRAL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.87▼ | 10.06▼ | 10.06▼ | 10.44▼ | 9.58▲ |
MA10 | 9.94▼ | 10.02▼ | 9.90▼ | 10.61▼ | 9.16▲ |
MA20 | 10.04▼ | 9.74▲ | 9.73▲ | 9.47▲ | 10.68▼ |
MA50 | 9.74▲ | 10.40▼ | 10.99▼ | 9.05▲ | 17.94▼ |
MA100 | 9.89▼ | 10.92▼ | 9.74▲ | 10.59▼ | 30.31▼ |
MA200 | 11.04▼ | 9.59▲ | 9.02▲ | 15.64▼ | 76.67▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.051▼ | 0.073▲ | 0.101▲ | 0.042▲ | 0.719▲ |
RSI | 44.891▼ | 46.117▼ | 45.392▼ | 50.440▲ | 41.853▼ |
STOCH | 16.697▼ | 71.660 | 82.957▲ | 51.483 | 28.005 |
WILL %R | -96.154▼ | -55.556 | -39.526 | -66.016 | -69.798 |
CCI | -96.078 | -39.879 | 23.524 | -8.069 | 54.335 |
Tuesday, May 13, 2025 03:50 PM
LYELL IMMUNOPHARMA ($LYEL) posted quarterly earnings results on Tuesday, May 13th. The company reported earnings of -$0.18 per share, beating estimates of -$0.18 by ...
|
Sunday, March 30, 2025 05:00 PM
$LYEL insiders have traded $LYEL stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales. Here’s a ...
|
Friday, March 28, 2025 08:07 AM
In this article, we are going to take a look at where Lyell Immunopharma, Inc. (NASDAQ:LYEL) stands against other cheapest stocks insiders are buying in March. After solid gains Monday ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 9.40 | 10.29 | 9.1601 | 9.74 | 76,732 |
12/06/25 | 9.21 | 10.035 | 8.96 | 9.74 | 145,678 |
11/06/25 | 10.52 | 10.83 | 9.16 | 9.41 | 187,257 |
10/06/25 | 12.405 | 12.72 | 9.875 | 10.865 | 333,232 |
09/06/25 | 13.02 | 13.63 | 11.7459 | 12.47 | 197,280 |
06/06/25 | 11.42 | 13.73 | 10.87 | 12.76 | 383,600 |
05/06/25 | 13.62 | 13.6325 | 9.67 | 11.46 | 786,672 |
04/06/25 | 8.01 | 13.80 | 7.78 | 13.47 | 1,689,152 |
03/06/25 | 8.20 | 8.445 | 7.82 | 7.99 | 116,100 |
02/06/25 | 8.12 | 10.30 | 7.65 | 8.22 | 397,852 |
|
|
||||
|
|
||||
|
|